Literature DB >> 14618305

Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial.

Kristene E Whitmore1, Christopher K Payne, Ananias C Diokno, James Chivian Lukban.   

Abstract

Female patients with interstitial cystitis (IC) unresponsive to standard oral and intravesical therapy were enrolled at three clinical sites for percutaneous sacral nerve root stimulation (PNS) in a prospective, observational pilot study. Evaluation was in the form of a 3-day voiding diary completed both prior to and following the commencement of sacral nerve root stimulation. Symptoms were also assessed by the O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices (ICSI and ICPI). Baseline and test stimulation values for voiding diary parameters and O'Leary-Sant scores were compared to determine treatment efficacy. A total of 33 patients were enrolled. Statistically significant improvements were seen in frequency, pain, average voided volume and maximum voided volume. Significant improvements were also seen in ICSI and ICPI scores. Subacute PNS appears to be effective in reducing symptom severity and increasing voided volumes in patients with IC previously unresponsive to standard therapy.

Entities:  

Mesh:

Year:  2003        PMID: 14618305     DOI: 10.1007/s00192-003-1080-1

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  22 in total

1.  Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group.

Authors:  R A Schmidt; U Jonas; K A Oleson; R A Janknegt; M M Hassouna; S W Siegel; P E van Kerrebroeck
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

2.  Sacral nerve root neuromodulation: an effective treatment for refractory urge incontinence.

Authors:  H S Shaker; M Hassouna
Journal:  J Urol       Date:  1998-05       Impact factor: 7.450

3.  Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention.

Authors:  H S Shaker; M Hassouna
Journal:  J Urol       Date:  1998-05       Impact factor: 7.450

4.  The interstitial cystitis symptom index and problem index.

Authors:  M P O'Leary; G R Sant; F J Fowler; K E Whitmore; J Spolarich-Kroll
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

5.  Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987.

Authors:  J Y Gillenwater; A J Wein
Journal:  J Urol       Date:  1988-07       Impact factor: 7.450

Review 6.  Pain mechanisms: a new theory.

Authors:  R Melzack; P D Wall
Journal:  Science       Date:  1965-11-19       Impact factor: 47.728

7.  Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis.

Authors:  T C Chai; C Zhang; J W Warren; S Keay
Journal:  Urology       Date:  2000-05       Impact factor: 2.649

8.  Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation.

Authors:  U Jonas; C J Fowler; M B Chancellor; M M Elhilali; M Fall; J B Gajewski; V Grünewald; M M Hassouna; U Hombergh; R Janknegt; P E van Kerrebroeck; A A Lylcklama a Nijeholt; S W Siegel; R A Schmidt
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

9.  Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis.

Authors:  C F Maher; M P Carey; P L Dwyer; P L Schluter
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

Review 10.  A neurologic basis for the overactive bladder.

Authors:  W C de Groat
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

View more
  13 in total

Review 1.  Sacral neuromodulation stimulation for IC/PBS, chronic pelvic pain, and sexual dysfunction.

Authors:  Jennifer Yonaitis Fariello; K Whitmore
Journal:  Int Urogynecol J       Date:  2010-12       Impact factor: 2.894

Review 2.  Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain.

Authors:  Robert D Mayer; Fred M Howard
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

3.  Sacral neuromodulation treating chronic pelvic pain: a meta-analysis and systematic review of the literature.

Authors:  Amr Mahran; Gina Baaklini; Daisy Hassani; Hassan A Abolella; Ahmed S Safwat; Mandy Neudecker; Adonis K Hijaz; Sangeeta T Mahajan; Steven W Siegel; Sherif A El-Nashar
Journal:  Int Urogynecol J       Date:  2019-03-14       Impact factor: 2.894

Review 4.  [Interstitial cystitis : Diagnosis and pharmacological and surgical therapy].

Authors:  A Gonsior; J Neuhaus; L C Horn; T Bschleipfer; J-U Stolzenburg
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

Review 5.  Minimally invasive therapies for chronic pelvic pain syndrome.

Authors:  Salim A Wehbe; Jennifer Y Fariello; Kristene Whitmore
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

Review 6.  Interventional therapies for controlling pelvic pain: what is the evidence?

Authors:  Isabel C Green; Sarah L Cohen; Dayna Finkenzeller; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2010-02

7.  National trends in the usage and success of sacral nerve test stimulation.

Authors:  Anne P Cameron; Jennifer T Anger; Rodger Madison; Christopher S Saigal; J Quentin Clemens
Journal:  J Urol       Date:  2011-01-19       Impact factor: 7.450

Review 8.  Interstitial cystitis and the overlap with overactive bladder.

Authors:  Christopher S Elliott; Christopher K Payne
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

9.  Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain.

Authors:  Nasim Zabihi; Arthur Mourtzinos; Mary Grey Maher; Shlomo Raz; Larissa V Rodríguez
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-10

Review 10.  Grading of evidence for bladder pain syndrome: a comparative review of study quality assessment methods.

Authors:  S A Tirlapur; K S Khan
Journal:  Int Urogynecol J       Date:  2013-11-23       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.